Dengue fever: a harmful disease in patients with thrombocytopenia?

We describe 2 patients with autoimmune thrombocytopenic disease who developed classic dengue fever associated with serious bleeding and extremely low platelet counts (1000 cells/mm(3) and 3000 cells/mm(3), respectively). Such patients should be properly advised as to the possibility that common dengue fever may substantially enhance their risk for hemorrhagic complications.

[1]  D. Gubler,et al.  Dengue and dengue hemorrhagic fever : Its history and resurgence as a global public health problem , 1997 .

[2]  V. L. La Russa,et al.  Dengue-2 virus infection of human bone marrow: characterization of dengue-2 antigen-positive stromal cells. , 1996, The American journal of tropical medicine and hygiene.

[3]  G. Kuno,et al.  Dengue and dengue haemorrhagic fever. , 1998, Releve epidemiologique hebdomadaire.

[4]  S. Kar,et al.  Ivermectin in the treatment of bancroftian filarial infection in Orissa, India. , 1993, The Southeast Asian journal of tropical medicine and public health.

[5]  V. Suvatte,et al.  Abnormal hemostasis in dengue hemorrhagic fever. , 1993, The Southeast Asian journal of tropical medicine and public health.

[6]  P. Butthep,et al.  Dengue virus and endothelial cell: a related phenomenon to thrombocytopenia and granulocytopenia in dengue hemorrhagic fever. , 1993, The Southeast Asian journal of tropical medicine and public health.

[7]  D. Gubler,et al.  Dengue and Dengue Hemorrhagic Fever , 1998, Clinical Microbiology Reviews.

[8]  J. Chan,et al.  Letter to the editor: Dengue virus infection‐associated hemophagocytic syndrome , 1991, American journal of hematology.

[9]  W. Weir,et al.  Dengue haemorrhagic fever: a risk of returning home. , 1991, BMJ.

[10]  N. Young.  Hematologic and hematopoietic consequences of B19 parvovirus infection. , 1988, Seminars in hematology.

[11]  H. Bierman,et al.  DENGUE FEVER: A THROMBOCYTOPENIC DISEASE? , 1964, JAMA.